Abstract
Editorial: Recent Advances in Cardiotoxicity Testing.
Highlights
Drug induced cardiotoxicity is a major cause of market withdrawal (Onakpoya et al, 2016)
The last decade has seen an explosion of cancer therapies, which while effective can lead to several cardiovascular toxicities
A close collaboration between cardiologists and oncologists had helped make these complications manageable ensuring that patients can be treated effectively (Campia et al, 2019)
Summary
Drug induced cardiotoxicity is a major cause of market withdrawal (Onakpoya et al, 2016). (2021) Editorial: Recent Advances in Cardiotoxicity Testing. In the last decade of the 20th century, eight non-cardiovascular drugs were withdrawn from clinical use because they prolonged the QT interval (Fermini and Fossa, 2003), resulting in ventricular arrhythmias and potentially sudden death.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
